The global AI drug discovery market, valued around $1 to $1.7 billion in 2023, will be worth a multiple of that by the decade’s end. Analysts project the sector could be worth $9 billion or more. 2024 Nobel Prize in Chemistry Recipients: David Baker Demis Hassabis John Jumper Achievement: Computational protein design and structure prediction…
Balancing on a tightrope, pharma’s generative AI journey straddles fear and FOMO
Pharma and biotech companies have had a spectrum of responses to the surge in generative artificial intelligence (AI). A recent Washington Post article describes an unnamed biotech firm that banned employees from using OpenAI’s ChatGPT despite its capability to bolster productivity given concerns over potential data leaks. At the same time, the burgeoning AI landscape…